Related Experiment Video
Updated: Jun 6, 2025

Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
Published on: July 20, 2022
Characterisation of patients who develop atrial fibrillation-induced cardiomyopathy
Nikhil Ahluwalia1,2, Shohreh Honarbakhsh1,2, Hakam Abbass1
1St Bartholomew's Hospital, London, UK.
Insights
Atrial fibrillation (AF)-induced cardiomyopathy (AIC) patients often have persistent cardiac dysfunction even after normal left ventricular ejection fraction (LVEF) in sinus rhythm. These findings suggest a subtle underlying cardiomyopathic process.
Area of Science:
- Cardiology
- Cardiac Electrophysiology
- Heart Failure Research
Background:
- Atrial fibrillation (AF)-induced cardiomyopathy (AIC) is defined by reduced left ventricular ejection fraction (LVEF) that normalizes after rhythm restoration.
- The underlying mechanisms and predisposing factors for AIC remain incompletely understood.
- Identifying persistent cardiomyopathic features post-ablation could elucidate disease progression.
Purpose of the Study:
- To assess cardiac function using detailed measures after successful catheter ablation (CA) in patients with AIC.
- To identify subtle cardiomyopathic features that persist even after LVEF normalization in AIC patients.
- To evaluate the utility of specific biomarkers and functional tests in detecting these persistent abnormalities.
Main Methods:
- Prospective evaluation of patients with persistent AF and LVEF <50% undergoing CA.
- Utilized echocardiography, cardio-pulmonary exercise testing, and NT-proBNP levels at baseline and 6 months post-CA.
- Assessed left ventricular longitudinal strain, left atrial reservoir strain (LARS), and functional capacity markers in AIC patients with recovered LVEF.
Main Results:
- 82.9% of participants recovered LVEF post-CA, meeting AIC criteria.
- Elevated NT-proBNP and persistent heart failure symptoms were common.
- Impaired LV longitudinal strain (58.8%) and LARS (26.5%) were observed, with significant overlap.
- 50% of patients with AIC had no traditional cardiovascular risk factors.
Conclusions:
- Patients with AIC exhibit persistent structural, metabolic, and heart failure biomarker abnormalities in sinus rhythm.
- These findings suggest a pre-existing, subtle cardiomyopathic process that predisposes individuals to AF-related left ventricular dysfunction.
- Further research is warranted to understand the etiology and implications of these persistent abnormalities.
Introduction:
Atrial fibrillation (AF)-induced cardiomyopathy (AIC) is retrospectively defined after normalisation of left ventricular ejection fraction (LVEF) in sinus rhythm. It is unclear why some patients develop AIC.
Hypothesis:
Patients with AIC have a subtle cardiomyopathic process that precedes their AF-mediated LVEF reduction. Detailed assessment of cardiac function after successful catheter ablation will reveal this.
Objective:
To evaluate the utility of measures to identify cardiomyopathic features that persist after LVEF normalisation in AIC.
Methods:
Patients with rate-controlled persistent AF and LVEF<50% undergoing catheter ablation (CA) were prospectively evaluated using echocardiography, cardio-pulmonary exercise testing and serum N-terminal pro b-type natriuretic peptide (NT-proBNP) at baseline and 6 months after CA. Participants with AIC, (LVEF recovery (≥50%) and no other cause for cardiac dysfunction) were evaluated using left ventricular (LV) longitudinal strain and left atrial (LA) reservoir strain (LARS). Changes in peak oxygen consumption and the minute ventilation/carbon dioxide production slope were measured as markers of functional capacity and ventilatory inefficiency. A control group of patients with persistent AF with preserved LVEF were also enrolled.
Results:
34/41 (82.9%) participants recovered LVEF in sinus rhythm; defined as AIC. NT-proBNP levels were elevated in 18 (52.9%), and 16 reported ongoing heart failure (HF) symptoms. 10 (29.4%) had no improvement in functional capacity, and seven (20.6%) showed persistent ventilatory inefficiency. 20 (58.8%) had impaired global LV longitudinal strain with a relative apical sparing pattern. Nine (26.5%) had impaired LARS. There was an overlap of these abnormalities. 32 (94.1%) demonstrated at least one, 17 (50.0%) having no cardiovascular risk factors. Patients with preserved LVEF during persistent AF had similar demographics but a lower burden of short R-R intervals (<660 ms) on Holter monitoring.
Discussion:
Abnormal structural, metabolic and HF biomarkers are seen in patients with AIC in sinus rhythm. These features may represent a precedent subtle cardiomyopathic process predisposing them to left ventricular systolic dysfunction in AF.
Trial Registration Number:
NCT04987723.
More Related Videos
08:31Isolation of Atrial Cardiomyocytes from a Rat Model of Metabolic Syndrome-related Heart Failure with Preserved Ejection Fraction
Published on: July 26, 2018
08:56Sterile Pericarditis in Aachener Minipigs As a Model for Atrial Myopathy and Atrial Fibrillation
Published on: September 24, 2021
Related Concept Videos
Myocarditis I: Introduction
Pathophysiology of Heart Failure
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
Myocarditis II: Clinical features and Diagnostic Tests
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
Rheumatic Heart Disease I: Introduction